Lengthened WHI Follow-up

Postmenopausal Estrogen Therapy

Andrew M. Kaunitz, MD


Journal Watch 

In This Article


Although these new findings from the WHI are intriguing, they do not imply that estrogen-only therapy should be recommended at this time for cardioprotection or breast cancer chemoprophylaxis. What these results do provide is reassurance to young menopausal women who are posthysterectomy and who present with bothersome vasomotor symptoms that use of estrogen therapy for as long as 6 years is safe.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.